Call for Abstract

4th International Congress on Addictive Behavior and Dual Diagnosis, will be organized around the theme “Exploring Advance Methodologies for Addiction & Mental Disorders Treatment”

Dual Diagnosis 2019 is comprised of 22 tracks and 125 sessions designed to offer comprehensive sessions that address current issues in Dual Diagnosis 2019.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 2-1Advanced Depression
  • Track 2-2Advances in clinical depression disorders
  • Track 2-3Advances in Depression test
  • Track 2-4Clinical Depression
  • Track 2-5Major Depression
  • Track 2-6Obsessive Compulsive Disorder
  • Track 2-7Severe Depression
  • Track 3-1Drug Addiction and Consequences
  • Track 3-2Drug dependence
  • Track 3-3Drug receptors
  • Track 3-4Drug tolerance
  • Track 3-5Drugs and their effects on addiction
  • Track 6-1Alcohol and Viral Hepatitis
  • Track 6-2Drug Abuse and Mental Health
  • Track 6-3Drug addiction in Children and Adolescents
  • Track 6-4Drug dependence
  • Track 6-5Drug induced disorders
  • Track 6-6HIV/AIDS
  • Track 6-7NSAIDS and Mental illness
  • Track 8-1Addiction & Toxicology
  • Track 8-2Alcohol detoxification using chemotherapeutic agents
  • Track 8-3Alcohol detoxification using chemotherapeutic agents
  • Track 8-4Alcoholic Liver Disease
  • Track 8-5Lung Health and Immunity
  • Track 9-1NSAIDS and Mental illness
  • Track 9-2Drug addiction in Children and Adolescents
  • Track 9-3Drug dependence
  • Track 9-4Drug Abuse and Mental Health
  • Track 9-5Drug induced disorders
  • Track 9-6HIV/AIDS
  • Track 9-7Alcohol and Viral Hepatitis
  • Track 9-8Adaptive Immune System
  • Track 9-9Lung Health and Immunity
  • Track 9-10Alcoholic Liver Disease
  • Track 9-11Neurogenetics of Substance Related Disorders
  • Track 9-12Mental health and symptoms
  • Track 11-1Advances in addiction psychology
  • Track 11-2Anxiety, Depression and Insomnia
  • Track 11-3Attention-deficit hyperactivity disorder
  • Track 11-4Marijuana use
  • Track 11-5Obsessive-Compulsive Disorder
  • Track 11-6Opioid dependence
  • Track 11-7Opioid treatment
  • Track 12-1Post-traumatic stress disorder
  • Track 12-2Emergency Mental health
  • Track 12-3Antisocial Personality Disorder
  • Track 12-4Behavioral addiction
  • Track 12-5Sexual Addiction
  • Track 12-6Gambling Addiction
  • Track 12-7Internet Addiction
  • Track 12-8Food addiction
  • Track 12-9Surgical addiction
  • Track 12-10Alcoholism- Amnesia, anxiety, depression
  • Track 12-11Amphetamines- schizophrenia
  • Track 13-1Mental health across the life span
  • Track 13-2Mental health in developing regions
  • Track 13-3Mental health services and policies
  • Track 13-4Philosophical and ethical themes in mental health
  • Track 14-1Advanced therapeutics in Bipolar treatment
  • Track 14-2Anxiety disorders
  • Track 14-3Bipolar Psychiatrists
  • Track 14-4Bipolar schizophrenia
  • Track 14-5Diagnosing bipolar test
  • Track 14-6Manic bipolar disorder
  • Track 14-7Personality disorder
  • Track 15-1Addictive Brain Disorder and Neurosurgery
  • Track 15-2Holistic and Alternative Treatment Approaches
  • Track 15-3Mindfulness
  • Track 15-4Neurodegenerative Disorder
  • Track 16-1Marijuana addiction
  • Track 16-2Alcoholism
  • Track 16-3Psychosis
  • Track 16-4Schizophrenia
  • Track 16-5Alcohol detoxification using chemotherapeutic agents
  • Track 16-6Autism spectrum disorder
  • Track 16-7Addiction and brain disorders
  • Track 16-8alcoholism and brain
  • Track 16-9Pain management
  • Track 16-10Pharmacotherapies
  • Track 16-11Alcoholic dementia
  • Track 17-1Cannabis - hallucinations and delusions
  • Track 17-2Cocaine - Dementia
  • Track 17-3Marijuana - Schizophrenia
  • Track 17-4Opioids - Insomnia
  • Track 17-5Ketamine - Antisocial personality disorders
  • Track 17-6Benzodiazepine - Sedation & Hypnotism
  • Track 17-7Advances in Neurotoxicology
  • Track 17-8Substance abuse disorders
  • Track 17-9Molecular Biology and Genetics
  • Track 17-10Smoking
  • Track 18-1Borderline personality therapy
  • Track 18-2Cognitive behavioral therapy
  • Track 18-3Dialectical behavioral therapy
  • Track 18-4Integrated treatment for dual disorders
  • Track 18-5Multidimensional family therapy
  • Track 18-6Nicotine replacement therapy
  • Track 18-7Prenatal Alcohol Exposure
  • Track 18-8Psychodynamic therapy
  • Track 19-1Mental Health
  • Track 19-2Emotional health
  • Track 19-3Behavioral health sciences
  • Track 19-4Spiritual sciences
  • Track 19-5Psychology and Education
  • Track 19-6Motivational interviewing
  • Track 19-7Contingency management
  • Track 19-8Residential treatment
  • Track 19-9Psychodynamic therapy
  • Track 19-10Dialectical behavioral therapy
  • Track 19-11Cognitive impairment
  • Track 20-1Alcohol Facts
  • Track 20-2Detoxification stage
  • Track 20-3Psychotropic substance abusers
  • Track 20-4Relapse and Management
  • Track 20-5Residential Drug Rehabilitation Program
  • Track 20-6Trans cranial Magnetic Stimulation
  • Track 22-1NSAIDS Addiction
  • Track 22-2Cocaine addiction
  • Track 22-3Hallucinogens Abuse
  • Track 22-4Tobacco abuse
  • Track 22-5Drug addiction diagnosis
  • Track 22-6Drug addiction recovery
  • Track 22-7Durg use and toxicity
  • Track 22-8Cognitive impairment
  • Track 22-9Psychodynamic therapy
  • Track 22-10Post-traumatic stress disorder